These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9950291)
41. Investigating herb-drug interactions: the effect of Citrus aurantium fruit extract on the pharmacokinetics of amiodarone in rats. Rodrigues M; Alves G; Falcão A Food Chem Toxicol; 2013 Oct; 60():153-9. PubMed ID: 23886819 [TBL] [Abstract][Full Text] [Related]
42. Bioequivalence study of two tablet formulations of ramipril in healthy volunteers. Allegrini A; Nuzzo L; Zucchelli M; Tavella-Scaringi A; Bucci M; Pavone D; Toniato E; Mezzetti A; Martinotti S; Bonani S Arzneimittelforschung; 2009; 59(8):392-6. PubMed ID: 19813461 [TBL] [Abstract][Full Text] [Related]
43. Bioequivalence evaluation of a triamterene-hydrochlorothiazide generic product: a new bioequivalence index for fixed-dose combinations. Hamidi M; Shahbazi MA; Azimi K Regul Toxicol Pharmacol; 2011 Feb; 59(1):149-56. PubMed ID: 21193005 [TBL] [Abstract][Full Text] [Related]
44. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913 [TBL] [Abstract][Full Text] [Related]
45. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations. Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328 [TBL] [Abstract][Full Text] [Related]
46. Absorption rate vs. exposure: which is more useful for bioequivalence testing? Tozer TN; Bois FY; Hauck WW; Chen ML; Williams RL Pharm Res; 1996 Mar; 13(3):453-6. PubMed ID: 8692741 [TBL] [Abstract][Full Text] [Related]
47. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
49. Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials. Marzo A; Monti NC; Vuksic D Eur J Clin Pharmacol; 1999 Nov; 55(9):627-31. PubMed ID: 10638390 [TBL] [Abstract][Full Text] [Related]
50. Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Meng X; Mojaverian P; Doedée M; Lin E; Weinryb I; Chiang ST; Kowey PR Am J Cardiol; 2001 Feb; 87(4):432-5. PubMed ID: 11179527 [TBL] [Abstract][Full Text] [Related]
51. Intestinal absorption of amiodarone in man. Pfeiffer A; Vidon N; Bovet M; Rongier M; Bernier JJ J Clin Pharmacol; 1990 Jul; 30(7):615-20. PubMed ID: 2391392 [TBL] [Abstract][Full Text] [Related]
52. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789 [TBL] [Abstract][Full Text] [Related]
53. [Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy]. Ding JJ; Jiao Z; Li ZD; Shi XJ Yao Xue Xue Bao; 2006 Sep; 41(9):893-8. PubMed ID: 17111840 [TBL] [Abstract][Full Text] [Related]
54. Analysis of risk factors in human bioequivalence study that incur bioinequivalence of oral drug products. Yamashita S; Tachiki H Mol Pharm; 2009; 6(1):48-59. PubMed ID: 19049413 [TBL] [Abstract][Full Text] [Related]
55. Power analyses of moment analysis parameter in bioequivalence tests. Kaniwa N; Ogata H; Aoyagi N; Takeda Y; Uchiyama M J Pharm Sci; 1989 Dec; 78(12):1020-4. PubMed ID: 2614692 [TBL] [Abstract][Full Text] [Related]
57. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics and bioequivalence evaluation of leflunomide tablets in Korean healthy volunteers. Lim YJ; Shim EJ; Kim HS; Oh M; Shon JH; Shin JG; Moon BS; Song GS; Kim EY Drug Res (Stuttg); 2013 Dec; 63(12):633-8. PubMed ID: 23884659 [TBL] [Abstract][Full Text] [Related]
59. Assessment of accuracy and precision of (99m)Tc-HEPIDA clearances determined by means of a simplified method. Surma MJ Nucl Med Rev Cent East Eur; 2009; 12(1):14-22. PubMed ID: 19554517 [TBL] [Abstract][Full Text] [Related]
60. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects. Almeida S; Filipe A; Neves R; Spínola AC; Tanguay M; Ortuño J; Farré A; Torns A Clin Ther; 2010 Mar; 32(3):556-74. PubMed ID: 20399993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]